Luís Correia

1.1k total citations
52 papers, 705 citations indexed

About

Luís Correia is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Luís Correia has authored 52 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 29 papers in Epidemiology and 15 papers in Surgery. Recurrent topics in Luís Correia's work include Inflammatory Bowel Disease (36 papers), Microscopic Colitis (28 papers) and IL-33, ST2, and ILC Pathways (5 papers). Luís Correia is often cited by papers focused on Inflammatory Bowel Disease (36 papers), Microscopic Colitis (28 papers) and IL-33, ST2, and ILC Pathways (5 papers). Luís Correia collaborates with scholars based in Portugal, United States and Brazil. Luís Correia's co-authors include Samuel Fernandes, Fernando Magro, Paula Lago, Ana Rita Gonçalves, Sónia Bernardo, Francisco Portela, Paula Ministro, Paula Moura Santos, A Valente and Cilénia Baldaia and has published in prestigious journals such as PLoS ONE, Trends in Ecology & Evolution and The Journal of Infectious Diseases.

In The Last Decade

Luís Correia

49 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luís Correia Portugal 14 509 417 220 135 64 52 705
Noa Krugliak Cleveland United States 15 497 1.0× 376 0.9× 192 0.9× 146 1.1× 77 1.2× 68 674
Annemarie C. de Vries Netherlands 15 436 0.9× 328 0.8× 293 1.3× 126 0.9× 126 2.0× 73 730
Seung‐Jae Myung South Korea 17 518 1.0× 444 1.1× 341 1.6× 104 0.8× 60 0.9× 61 755
María Dolores Martin‐Arranz Spain 13 384 0.8× 248 0.6× 254 1.2× 162 1.2× 63 1.0× 88 638
Cristina Bezzio Italy 14 362 0.7× 302 0.7× 204 0.9× 70 0.5× 107 1.7× 78 631
G. Vernier‐Massouille France 8 393 0.8× 299 0.7× 265 1.2× 83 0.6× 38 0.6× 12 590
Barbara D. Lovász Hungary 16 709 1.4× 605 1.5× 338 1.5× 119 0.9× 61 1.0× 46 890
Annalisa Aratari Italy 16 541 1.1× 465 1.1× 279 1.3× 55 0.4× 88 1.4× 42 742
Eran Zittan Israel 15 586 1.2× 456 1.1× 314 1.4× 135 1.0× 66 1.0× 41 742
Frank Czul United States 12 387 0.8× 363 0.9× 200 0.9× 118 0.9× 33 0.5× 25 610

Countries citing papers authored by Luís Correia

Since Specialization
Citations

This map shows the geographic impact of Luís Correia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Correia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Correia more than expected).

Fields of papers citing papers by Luís Correia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luís Correia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Correia. The network helps show where Luís Correia may publish in the future.

Co-authorship network of co-authors of Luís Correia

This figure shows the co-authorship network connecting the top 25 collaborators of Luís Correia. A scholar is included among the top collaborators of Luís Correia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luís Correia. Luís Correia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernandes, Samuel, Ana Rita Gonçalves, Paula Moura Santos, et al.. (2025). Early Top-Down Treatment With Biologics Improves the Rates of Transmural Remission in Crohn’s Disease—A Risk-Adjusted Propensity Score Matched Analysis. Inflammatory Bowel Diseases. 31(11). 3011–3020. 1 indexed citations
2.
Correia, Luís, et al.. (2025). Efficacy of the adjunctive use of photobiomodulation therapy in olfactory disorders in post-COVID-19 patients: A randomized controlled trial. Brazilian Journal of Otorhinolaryngology. 91(4). 101583–101583. 1 indexed citations
3.
Fernandes, Samuel, et al.. (2024). P254 Outcomes of endoscopic and histologic remission in ulcerative colitis under advanced therapy. Journal of Crohn s and Colitis. 18(Supplement_1). i601–i601. 1 indexed citations
4.
5.
Dias, Cláudia Camila, Paula Ministro, Raquel Gonçalves, et al.. (2022). The Magnitude of Crohn’s Disease Direct Costs in Health Care Systems (from Different Perspectives): A Systematic Review. Inflammatory Bowel Diseases. 28(10). 1527–1536. 11 indexed citations
6.
Ministro, Paula, Raquel Gonçalves, Diana Carvalho, et al.. (2022). Incidence Trends of Inflammatory Bowel Disease in a Southern European Country: A Mirror of the Western World?. Clinical and Translational Gastroenterology. 13(5). e00481–e00481. 10 indexed citations
7.
Magro, Fernando, Francisco Portela, Paula Lago, et al.. (2022). Burden of Disease and Cost of Illness of Inflammatory Bowel Diseases in Portugal. GE Portuguese Journal of Gastroenterology. 30(4). 283–292. 4 indexed citations
8.
Magro, Fernando, Paula Ministro, Paula Lago, et al.. (2021). Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta‐analysis. United European Gastroenterology Journal. 10(1). 54–72. 3 indexed citations
9.
10.
Dias, Cláudia Camila, Luís Correia, Francisco Portela, et al.. (2019). Hospitalization trends of the Inflammatory Bowel Disease landscape: A nationwide overview of 16 years. Digestive and Liver Disease. 51(7). 952–960. 21 indexed citations
11.
Fernandes, Samuel, Sónia Bernardo, Carolina Simões, et al.. (2019). Proactive Infliximab Drug Monitoring Is Superior to Conventional Management in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 26(2). 263–270. 70 indexed citations
12.
Dias, Cláudia Camila, Francisco Portela, Samuel Fernandes, et al.. (2018). The timing of early therapeutic strategies has a significant impact on Crohn’s disease prognosis. Digestive and Liver Disease. 50(5). 462–468. 4 indexed citations
13.
Fernandes, S., Helena Nunes‐Cabaço, Luís Correia, et al.. (2017). HIV-2 infection is associated with preserved GALT homeostasis and epithelial integrity despite ongoing mucosal viral replication. Mucosal Immunology. 11(1). 236–248. 16 indexed citations
14.
Dias, Cláudia Camila, Pedro Pereira Rodrigues, Samuel Fernandes, et al.. (2017). The risk of disabling, surgery and reoperation in Crohn’s disease – A decision tree-based approach to prognosis. PLoS ONE. 12(2). e0172165–e0172165. 14 indexed citations
15.
Fernandes, Samuel, Sónia Bernardo, Isadora Rosa, et al.. (2017). Transmural Healing Is Associated with Improved Long-term Outcomes of Patients with Crohnʼs Disease. Inflammatory Bowel Diseases. 23(8). 1403–1409. 142 indexed citations
16.
Fernandes, Samuel, et al.. (2016). Severe ischemic colitis following olanzapine use - A case report. Revista Española de Enfermedades Digestivas. 108(9). 595–8. 5 indexed citations
17.
Fernandes, S., Carla Pinto Moura, Cilénia Baldaia, et al.. (2015). P132. Could the cytokines concentration be a marker of IBD activity and be usefull in evaluation of IBD differentiation?. Journal of Crohn s and Colitis. 9(suppl 1). S142–S143. 1 indexed citations
18.
Cravo, Marília, S. Velho, Paula Ministro, et al.. (2013). IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis. European Journal of Gastroenterology & Hepatology. 26(1). 26–32. 13 indexed citations
19.
Lenz, Luciano, Luís Correia, Fernanda Prata Martins, et al.. (2011). Comparative study of bipolar eletrocoagulation versus argon plasma coagulation for rectal bleeding due to chronic radiation coloproctopathy. Endoscopy. 43(8). 697–701. 19 indexed citations
20.
Martins, Fernanda Prata, et al.. (2008). Obstructive jaundice caused by hemobilia after liver biopsy. Endoscopy. 40(S 02). E265–E266. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noa Krugliak Cleveland Breakdown of academic impact, for papers by Annemarie C. de Vries Breakdown of academic impact, for papers by Seung‐Jae Myung Breakdown of academic impact, for papers by María Dolores Martin‐Arranz Breakdown of academic impact, for papers by Cristina Bezzio Breakdown of academic impact, for papers by G. Vernier‐Massouille Breakdown of academic impact, for papers by Barbara D. Lovász Breakdown of academic impact, for papers by Annalisa Aratari Breakdown of academic impact, for papers by Eran Zittan Breakdown of academic impact, for papers by Frank Czul
Rankless by CCL
2026